12 September 1997
Acquired systemic tolerance to islet allografts induced by ntrathymic inoculation of
Soji F Oluwole, Nepal C Chowdhury, Ming-Xing Jin, Mark A Hardy
alloantigens - a brief review
Ann Transplant 1997; 2(3): 81-85 :: ID: 497280
While transplantation remains the only potentially useful treatment for end-stage organ failure, its widespread use is limited by donor organ failure due to immunological rejection. At present, the success of clinical organ transplantation is dependent on long-term use of non-specific immunosuppressive agents that cause significant morbidity and mortality. Despite recent improvements in graft survival due to the use of potent immunosuppressive drugs like cyclosporine and FK 506, graft rejection continues to occur...
Keywords: acquired thymic tolerance, Alloantigens, Islets
Most Viewed Current Articles
26 Jan 2022 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review articleNormothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588